Partners:
Below is a sneak peek at the exciting line-up of research talks planned for the annual meeting specifically for members of the NIMH Outreach Partnership Program.
On Wednesday, March 13, you will hear from leading authorities about the innovative research being conducted to advance the understanding and treatment of mental disorders at the Division of Intramural Research Programs at NIMH in Bethesda, Maryland.
Identifying and Treating Childhood Mental Disorders
 Childhood Anxiety Disorders: Daniel Pine, M.D.
Dr. Pine, Chief of the Section on Development and Affective Neuroscience conducts research seeking to identify the genetic and environmental factors underlying these mental illnesses so clinicians can identify who might be prone to them, spot early symptoms, and tailor treatments more precisely to individual patients. Find out more about his work in these New York Times and NPR interviews.
|
 Bipolar Disorder and Severe Mood Dysregulation: Ellen Leibenluft, M.D.
Dr. Leibenluft, Chief of the Section on Bipolar Spectrum Disorders studies the brain mechanisms mediating bipolar disorder and severe irritability in youth. Learn more in this NIMH video about childhood bipolar disorder as well as this review article about her research on the diagnosis of bipolar disorder and severe mood dysregulation in children.
|
The Teen Brain
 Jay Giedd, M.D.
For more than 20 years, Dr. Giedd Chief of the Section on Brain Imaging, Child Psychiatry Branch, has studied the development of the adolescent brain. His research team uses cutting edge technologies to explore the relationship between genes, brain, and behavior in healthy development and in neuropsychiatric disorders of childhood onset. Read about how this research is changing how we think about the "teen brain" in this Frontline interview and Time Magazine article.
|
Advancing the Treatment of Depression
New Treatments for the Perinatal Period: Pedro Martinez, M.D.
Dr. Martinez, Chief of the Reproductive Psychiatry Clinic at NIMH will share exciting research being conducted about the pathophysiology of perinatal mood disorders and alternative treatments. Hear more about the groundbreaking research into new postpartum depression (PPD) treatments in this NIMH video about PPD.
|
Fast-Acting Medications: Carlos Zarate, M.D.
Dr. Zarate, Chief of Experimental Therapeutics & Pathophysiology Branch and Section Neurobiology and Treatment of Mood Disorders at NIMH will discuss his pioneering research on fast-acting medications for the treatment of depression. Read about the recent findings from this research in this NIMH press release and ABC News story.
|
Check out full details of the meeting's agenda.
Not registered? Contact Frank Bajowksi at fbajowski@capconcorp.com to find out how you can register onsite.
Looking forward to seeing you!
| 
